Document is current
Any future updates will be listed below
-
Authors
Glover, Hannah L. http://orcid.org/0000-0003-3809-9977
Schreiner, Annabell http://orcid.org/0000-0002-4827-4612
Dewson, Grant http://orcid.org/0000-0003-4251-8898
Tait, Stephen W. G. http://orcid.org/0000-0001-7697-132X
-
Funding
Funding for this research was provided by:
Cancer Research UK (DRCNPG-Jun22\100011, DRCNPG-Jun22\100011)
- License Information
-
More Information
Article History
Received: 9 February 2024
Accepted: 26 April 2024
First Online: 20 June 2024
Competing interests
: S.T. consults for Exo Therapeutics. A.S. and G.D. are employees of the Walter and Eliza Hall Institute, which receives royalty payments relating to the use of Venclexta (venetoclax).
